Drug Shortage Report for MYLAN-TADALAFIL

Last updated on 2019-06-19 History
Report ID 73957
Drug Identification Number 02410656
Brand name MYLAN-TADALAFIL
Common or Proper name TADALAFIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4BL CA
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-06
Actual start date
Estimated end date 2019-08-30
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v49 2019-06-19 English Compare
v48 2019-06-18 French Compare
v47 2019-06-18 English Compare
v46 2019-06-07 English Compare
v45 2019-06-04 French Compare
v44 2019-06-04 English Compare
v43 2019-06-01 English Compare
v42 2019-05-28 French Compare
v41 2019-05-28 English Compare
v40 2019-05-28 English Compare
v39 2019-05-22 French Compare
v38 2019-05-22 English Compare
v37 2019-05-21 English Compare
v36 2019-05-14 French Compare
v35 2019-05-14 English Compare
v34 2019-05-14 English Compare
v33 2019-05-08 French Compare
v32 2019-05-08 English Compare
v31 2019-04-30 French Compare
v30 2019-04-30 English Compare

Showing 1 to 20 of 49